ISSN: 0973-7510
E-ISSN: 2581-690X
Exopolysaccharide (EPS) was extracted and purified from a newly isolated Bacillus amyloliquefaciens strain, C-1. The anti-tumor activities of this EPS were tested in vitro. C-1 EPS exhibited good and direct, dose-dependent in vitro anti-proliferative effects on 6 human cancer cell lines. The inhibition rates of 7 mg/ml EPS on tumor cells SGC-7901, HeLa, A549, 7721, 7402, and MCF-7 were 73.2%, 78.6%, 65.0%, 64.0%, 41.1%, and 57.7%, respectively. The anti-proliferative effect of EPS was associated with the direct induction of apoptotic cell death, rather than the cell cycle. It was also verified that the expression of anti-apoptotic Bcl-2 family proteins was decreased. These results collectively show that this EPS has considerable potential for use in medical compounds.
Exopolysaccharides, Anti-tumor activity, Cell apoptosis, Bacillus amyloliquefaciens C-1
© The Author(s) 2014. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.